1
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients
Condition(s):Chronic Hepatitis bLast Updated:October 13, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Hepatitis bLast Updated:October 13, 2022Recruiting
Condition(s):Elevated Blood Lead LevelsLast Updated:July 14, 2023Completed
Condition(s):Non-small Cell Lung CancerLast Updated:August 2, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.